HTG Molecular Diagnostics, Inc. (HTGMQ)

OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Jul 13, 2026
Market Cap2.00 -99.1%
Revenue (ttm)6.21M -28.2%
Net Income-20.15M
EPS-15.79
Shares Out 2.21M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,635
Open0.000001
Previous Close0.0001
Day's Range0.000001 - 0.000001
52-Week Range0.000001 - 0.0001
Beta-126.52
Analystsn/a
Price Targetn/a
Earnings Daten/a

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company dist... [Read more]

Sector Healthcare
Founded 1997
Employees 54
Stock Exchange OTCMKTS
Ticker Symbol HTGMQ
Full Company Profile